Heat Biologics, Inc. to Present at 25th Annual Piper Jaffray Healthcare Conference

Dec 2, 2013

Heat Biologics Successfully Completes Manufacturing of HS-410 to Start Phase 1/2 Bladder Cancer Trial

Nov 25, 2013

Heat Biologics, Inc. Reports Third Quarter 2013 Financial Results and Provides Clinical Programs Review

Nov 14, 2013

Heat Biologics, Inc. to Present at 12th Annual BIO Investor Forum

Oct 2, 2013

Heat Biologics Files IND for Bladder Cancer Product Candidate

Oct 1, 2013

Heat Biologics Appoints Louis C. Bock to Board of Directors

Sep 25, 2013

Heat Biologics, Inc. to Present at Aegis Capital Corp. 2013 Healthcare Conference

Sep 19, 2013

Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option

Sep 4, 2013

Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option

Aug 13, 2013

Heat Biologics, Inc. Announces Closing of Initial Public Offering of 2,500,000 Shares of Common Stock

Jul 29, 2013